The US Food and Drug Administration (FDA) is warning about the risk of a rare but serious allergic reaction with the medicine ...

US clinical-stage biotech ArriVent BioPharma has entered into an exclusive license agreement with Shanghai-based Lepu ...

Suzhou, China-based Ascentage Pharma revealed that it plans to raise $149 million by offering 7.3 million American Depositary ...

Shares of Coherus BioSciences rose 4.5% to $1.8 in pre-market activity after it released positive med-stage results for its ...

The US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for RP1 (vusolimogene ...

Icelandic drug discovery and development company Arctic Therapeutics has announced the successful closing of a 26.5 million ...

T-cell immunotherapy company Atara Biotherapeutics closed 8% lower on Tuesday, having lost 41% of its stock market value on ...

Kyverna Therapeutics appoints Naji Gehchan as CMO to advance KYV-101, its CD19-directed CAR-T therapy for autoimmune diseases ...

The FDA issues a warning letter to Sanofi over manufacturing violations at its Massachusetts site, citing contamination and ...

Spektus Pharma, a Quebec-based specialty pharma company developing therapeutics for the treatment of CNS disorders, has ...

Sanofi secures EU approval for Sarclisa with VRd for newly diagnosed multiple myeloma patients ineligible for stem cell ...

UK pharma major AstraZeneca today revealed that, this week, it has received two positive recommendations from the National ...